Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01627821 · ClinicalTrials.gov registry record · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
A NA study of Heart Failure, sponsored by Jarvik Heart.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT01627821: Recruiting NA study of Heart Failure, sponsored by Jarvik Heart.
NCT01627821 is a NA study of Heart Failure that is actively recruiting participants, run by Jarvik Heart. The registered enrollment target is 350 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01627821, a NA study of Heart Failure, is actively recruiting participants, sponsored by Jarvik Heart.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This investigation will be conducted as an interventional intention-to-treat clinical study in a population of end stage heart failure patients who meet specific inclusion and exclusion criteria. The multi-center study will be prospective, dual-armed, non-blinded (open-label) and randomized, comparing a treatment group receiving the Jarvik 2000 LVAS with Post-Auricular Connector to an active control group treated with the PMA approved Thoratec HeartMate® II LVAS for Destination Therapy.
Conditions Studied
Interventions
- DEVICE Jarvik 2000 VAS
- DEVICE HeartMate II
Study Locations (1)
New York
- Columbia/NY Presbyterian - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2013-02 |
| Est. Completion | 2025-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01627821
The ClinicalTrials.gov registry entry for NCT01627821 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (83% lower). The listed sponsor is Jarvik Heart, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Jarvik 2000 VAS is the first listed.
NCT01627821 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01627821 about?
NCT01627821 is a clinical study titled "Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study". This investigation will be conducted as an interventional intention-to-treat clinical study in a population of end stage heart failure patients who meet specific inclusion and exclusion criteria. The multi-center study will be prospective, dual-armed, non-blinded (open-label) and randomized, compari...
What is the current status of trial NCT01627821?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2013-02. Estimated completion is 2025-03.
What conditions does trial NCT01627821 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT01627821?
The interventions under investigation include: Jarvik 2000 VAS (DEVICE), HeartMate II (DEVICE).
Who is sponsoring clinical trial NCT01627821?
This trial is sponsored by Jarvik Heart, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01627821 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.